WITHDRAWN: Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study

Abdwani R Rizvi S El-Nour I. Childhood systemic lupus erythematosus in sultanate of Oman: demographics and clinical analysis. Lupus 2008; 17: 683–686.

Huang J Yeh K Yao T , et al. Pediatric lupus in Asia. Lupus 2010; 19: 1414–1418.

Al Arfaj A Khalil N. Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia. Lupus 2009; 18: 465–473.

Petri M Orbai AM Alarcón GS , et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2677–2686.

Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.

Feletar M Ibañez D Urowitz MB Gladman DD. The impact of the 1997 update of the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus: what has been changed? Arthritis Rheum 2003; 48: 2067–2069.

Granata G Didona D Stifano G Feola A Granata M. Macrophage activation syndrome as onset of systemic lupus erythematosus: a case report and a review of the literature. Case Rep Med 2015; 2015: 1–4.

Bashal F. Hematological disorders in patients with systemic lupus erythematosus. Open Rheumatol J 2013; 7: 87–95.

Hepburn AL Narat S Mason JC. The management of peripheral blood cytopenias in systemic lupus erythematosus. Rheumatology 2010; 49: 2243–2254.

Anolik JH Campbell D Felgar RE , et al. The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus. Arthritis Rheum 2003; 48: 455–459.

Zandman-Goddard G Levy Y Shoenfeld Y. Intravenous immunoglobulin therapy and systemic lupus erythematosus. Clin Rev Allergy Immunol 2005; 29: 219–228.

Abu-Shakra M Shoenfeld Y. Azathioprine therapy for patients with systemic lupus erythematosus. Lupus 2001; 10: 152–153.

Jung J-H Soh M-S Ahn Y-H , et al. Thrombocytopenia in systemic lupus erythematosus: clinical manifestations, treatment, and prognosis in 230 patients. Medicine 2016; 95: e2818.

Packman CH. The clinical pictures of autoimmune hemolytic anemia. Transfus Med Hemother 2015; 42: 317–324.

Cullis J. Anaemia of chronic disease. Clin Med 2013; 13: 193–196.

Gulay CB Dans LF. Clinical presentations and outcomes of Filipino juvenile systemic lupus erythematosus. Pediatr Rheumatol 2011; 9: 7.

Ilias M Ali J Ismail N Rostenberghe HV Rahman AA. Pediatric systemic lupus erythematosus (SLE) manifestations and outcomes in a tertiary hospital. Lupus 2017; 2: 6–3.

Muzaffer MA Al-Mayouf SM. Clinical and laboratory variables of childhood systemic lupus erythematosus in Western province of Saudi Arabia. Rheumatol Int 2011; 31: 23–26.

Tarr T Dérfalvi B Győri N , et al. Similarities and differences between pediatric and adult patients with systemic lupus erythematosus. Lupus 2015; 24: 796–803.

Hanaoka H Iida H Kiyokawa T Takakuwa Y Kawahata K. A positive direct Coombs’ test in the absence of hemolytic anemia predicts high disease activity and poor renal response in systemic lupus erythematosus. Lupus 2018; 27: 2274–2278.

Skare T Picelli L Dos Santos TAG Nisihara R. Direct antiglobulin (coombs) test in systemic lupus erythematosus patients. Clin Rheumatol 2017; 36: 2141–2144.

Beyan E Beyan C Turan M. Hematological presentation in systemic lupus erythematosus and its relationship with disease activity. Hematology 2007; 12: 257–261.

Lertchaisataporn K Kasitanon N Wangkaew S Pantana S Sukitawut W Louthrenoo W. An evaluation of the association of leukopenia and severe infection in patients with systemic lupus erythematosus. J Clin Rheumatol 2013; 19: 115–120.

Samohvalov E Samohvalov S. The pattern of anemia in lupus. In: Khan J (ed) Current Topics in Anemia. IntechOpen, 2018, 165.

Salah S Lotfy HM Sabry SM Hamshary AE Taher H. Systemic lupus erythematosus in Egyptian children. Rheumatol Int 2009; 29: 1463–1468.

Carli L Tani C Vagnani S Signorini V Mosca M. Leukopenia, lymphopenia, and neutropenia in systemic lupus erythematosus: prevalence and clinical impact—a systematic literature review. Semin Arthritis Rheum 2015; 45: 190–194.

Sobhy N Niazy MH Kamal A. Lymphopenia in systemic lupus erythematosus patients: is it more than a laboratory finding? Egypt Rheumatol 2020; 42: 23–26.

Ng W Chu C Wu AKL Cheng VCC Yuen KY. Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus. Qjm 2006; 99: 37–47.

Ahluwalia J Singh S Naseem S , et al. Antiphospholipid antibodies in children with systemic lupus erythematosus: a long-term clinical and laboratory follow-up status study from northwest India. Rheumatol Int 2014; 34: 669–673.

von Scheven E Glidden DV Elder ME. Anti–β2‐glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Care Res 2002; 47: 414–420.

Ünlü O Zuily S Erkan D. The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus. Eur J Rheumatol 2016; 3: 75–84.

Woo K-S Kim K-E Kim JM , et al. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus. Korean J Lab Med 2010; 30: 38–44.

Teke HÜ Cansu DÜ Korkmaz C. Detailed features of hematological involvement and medication-induced cytopenia in systemic lupus erythematosus patients: single center results of 221 patients. Eur J Rheumatol 2017; 4: 87–92.

González-Naranjo LA Betancur OM Alarcón GS , et al. Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: data from a multiethnic Latin American cohort. Semin Arthritis Rheum 2016; 45: 675–683.

Schmugge M Revel-Vilk S Hiraki L Rand ML Blanchette VS Silverman ED. Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus. J Pediatr 2003; 143: 666–669.

Arroyo-Ávila M Santiago-Casas Y McGwin G , et al. Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort. Clin Rheumatol 2015; 34: 1217–1223.

Vila L Molina M Mayor A Peredo RA Santaella ML Vilá S. Clinical and prognostic value of autoantibodies in puerto ricans with systemic lupus erythematosus. Lupus 2006; 15: 892–898.

Baek S-W Lee M-W Ryu H-W , et al. Clinical features and outcomes of autoimmune hemolytic anemia: a retrospective analysis of 32 cases. Korean J Hematol 2011; 46: 111–117.

Gokce M Bilginer Y Besbas N , et al. Hematological features of pediatric systemic lupus erythematosus: suggesting management strategies in children. Lupus 2012; 21: 878–884.

Fayyaz A Igoe A Kurien BT , et al. Haematological manifestations of lupus. Lupus Sci Med 2015; 2: e000078.

Arnal C Piette J-c Léone J , et al. Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases. J Rheumatol 2002; 29: 75–83.

Nieto-Aristizabal I Martínez T Urbano M-A , et al. Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a single-center experience with 63 patients. Lupus 2019; 28: 1566–1570.

Serris A Amoura Z Terrier B , et al. Can rituximab be useful for treating SLE-Associated immune cytopenias? Results from a retrospective multicentre study on 62 patients. Washington, DC: American Society of Hematology, 2016.

Olfat M Silverman E Levy D. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus. Lupus 2015; 24: 966–972.

Kumar S Benseler SM Kirby-Allen M Silverman ED. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus. Pediatrics 2009; 123: e159–e163.

Alba P Karim M Hunt B. Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lupus 2003; 12: 633–635.

Newman K Owlia MB El-Hemaidi I Akhtari M. Management of immune cytopenias in patients with systemic lupus erythematosus—old and new. Autoimmunity Rev 2013; 12: 784–791.

Vasoo S Thumboo J Fong K. Refractory immune thrombocytopenia in systemic lupus erythematosus: response to mycophenolate mofetil. Lupus 2003; 12: 630–632.